Company / Capital Expenditures
Cooper Companies (The) Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$362.4M
FY2025
5-year range
$214.4M / $421.2M
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#31 of 145
Health Care
What the data says
Cooper Companies (The)'s capital expenditures of $362M is higher than 79% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $127M in FY2017 to $421M in FY2024.
Based on SEC 10-K filings.
$362M in FY2025 with a 5-year CAGR of +3.1%. Top quartile in the Health Care sector.
Declined from $393M to $362M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +14.4%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
+34.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.1%, indicating consistent growth.
- In FY2025, capital expenditures decreased 14.0% year-over-year.
- Ranks #31 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $362.4M | -14.0% |
| FY2024 | $421.2M | +7.3% |
| FY2023 | $392.5M | +62.2% |
| FY2022 | $242.0M | +12.9% |
| FY2021 | $214.4M | -30.9% |
| FY2020 | $310.4M | +6.3% |
| FY2019 | $292.1M | +50.9% |
| FY2018 | $193.6M | +52.2% |
| FY2017 | $127.2M | -16.6% |
| FY2016 | $152.6M | -37.2% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026